 | Up a level |
Reiner, M F; Baumgartner, P; Wiencierz, A; Aeschbacher, S; Rodondi, N; Baretella, O; Kuehne, M; Moschovitis, G; Bonati, L H; Von Schacky, C; Luescher, T F; Camici, G G; Osswald, S; Conen, D; Beer, J H (October 2019). P3712The omega-3 fatty acid eicosapentaenoic acid (EPA) is inversely associated with ischemic brain infarcts in elderly patients with atrial fibrillation. European Heart Journal, 40(Supplement_1), p. 2312. 10.1093/eurheartj/ehz745.0566
Krisai, P; Blum, S; Aeschbacher, S; Beer, J H; Moschovitis, G; Witassek, F; Kobza, R; Rodondi, N; Mahmood, A; Meyer-Zuern, C; Kuehne, M; Osswald, S; Conen, D (October 2019). P1876Atrial fibrillation related symptoms and cardiovascular outcomes. European Heart Journal, 40(Supplement_1), p. 1168. 10.1093/eurheartj/ehz748.0625
Blum, S; Kuehne, M; Rodondi, Nicolas; Mueller, A; Ammann, P; Moschovitis, G; Kobza, R; Schlaepfer, J; Meyre, P; Bonati, L H; Ehret, G; Sticherling, C; Schwenkglenks, M; Osswald, S; Conen, D (August 2018). 1358 Prevalence of silent vascular brain lesions among patients with atrial fibrillation and no known history of stroke. European Heart Journal, 39(suppl_1), p. 264. Oxford Academic 10.1093/eurheartj/ehy565.1358
